Cargando…

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases

Since its discovery, many adhere to the view that asymmetric dimethylarginine (ADMA), as an inhibitor of the synthesis of nitric oxide (NO), contributes to the pathogenesis of various diseases. Particularly, this is evident in disease of the cardiovascular system, in which endothelial dysfunction re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lüneburg, Nicole, Harbaum, Lars, Hennigs, Jan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955646/ https://www.ncbi.nlm.nih.gov/pubmed/24719871 http://dx.doi.org/10.1155/2014/501612

Ejemplares similares

Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension
por: Hennigs, Jan K., et al.
Publicado: (2014)

N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
por: Harbaum, Lars, et al.
Publicado: (2014)

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
por: Hannemann, Juliane, et al.
Publicado: (2020)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

Organbezogene Folgeerscheinungen von COVID‑19 bei Erwachsenen
por: Hennigs, Jan K., et al.
Publicado: (2022)

Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2016)

Respiratory muscle dysfunction in long-COVID patients
por: Hennigs, Jan K., et al.
Publicado: (2022)

Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach
por: Oliva-Damaso, Elena, et al.
Publicado: (2019)

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
por: Scott, Jeremy A., et al.
Publicado: (2014)

Iron Overload Damages the Endothelial Mitochondria via the ROS/ADMA/DDAHII/eNOS/NO Pathway
por: He, Huan, et al.
Publicado: (2019)

From arginine methylation to ADMA: A novel mechanism with therapeutic potential in chronic lung diseases
por: Zakrzewicz, Dariusz, et al.
Publicado: (2009)

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
por: Li Volti, Giovanni, et al.
Publicado: (2011)

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016)

Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease
por: Arefin, Samsul, et al.
Publicado: (2023)

Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study
por: Harbaum, Lars, et al.
Publicado: (2021)

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA
por: Smith, Caroline L, et al.
Publicado: (2005)

Association of mortality and endothelial dysfunction with serum ADMA level in COVID-19 patients
por: Karacaer, Cengiz, et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertension
por: Ostermann, Jonna, et al.
Publicado: (2023)

ADMA in Vascular Disease: More than a Marker?
Publicado: (2005)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review
por: Dymara-Konopka, Weronika, et al.
Publicado: (2019)

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches
por: Hennigs, Jan K., et al.
Publicado: (2021)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

L-citrulline for protection of endothelial function from ADMA–induced injury in porcine coronary artery
por: Xuan, Chao, et al.
Publicado: (2015)

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
por: Nijveldt, RJ, et al.
Publicado: (2003)

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
por: Franceschelli, Sara, et al.
Publicado: (2013)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease
por: Janes, Francesco, et al.
Publicado: (2019)

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway
por: Yang, Dafeng, et al.
Publicado: (2018)

The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome
por: Sozio, Emanuela, et al.
Publicado: (2023)

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension
por: Dittrich, Anna M., et al.
Publicado: (2023)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
por: Dowsett, Laura, et al.
Publicado: (2020)

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
por: Harbaum, Lars, et al.
Publicado: (2017)

A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach
por: Singh, Jaipal, et al.
Publicado: (2022)

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study
por: Simon, Marcel, et al.
Publicado: (2016)

Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis
por: Tan, Chaochao, et al.
Publicado: (2021)

Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?
por: Lüneburg, Nicole, et al.
Publicado: (2016)

Ammonia reduces intracellular ADMA level in cultured astrocytes and endothelial cells: possible involvement of increased y+LAT2-mediated efflux
por: Milewski, Krzysztof, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u9mp6tbtqk19grmpqfnn9mgu9t